On the basis of a series of in vitro and in vivo experiments evaluating the inflammatory response, oxidative stress, and apoptosis, we identified that lncRNA 6406 could attenuate sepsis-associated AKI by modulating the miR-687/PTEN signaling pathway, which may provide a new therapeutic approach for AKI in the future. The gene discussed is PTEN; the disease is acute kidney injury.